- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 279/14 - Derivatives of guanidine, i.e. compounds containing the group the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
Patent holdings for IPC class C07C 279/14
Total number of patents in this class: 268
10-year publication summary
|
18
|
23
|
26
|
21
|
25
|
32
|
18
|
21
|
22
|
15
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Alzchem Trostberg GmbH | 261 |
12 |
| ARK Diagnostics, Inc. | 37 |
8 |
| Exerkine Corporation | 38 |
6 |
| Evonik Operations GmbH | 4384 |
6 |
| ThermoLife International, LLC | 186 |
5 |
| Inspirna, Inc. | 33 |
5 |
| Colgate-Palmolive Company | 5733 |
4 |
| Massachusetts Institute of Technology | 10282 |
4 |
| Arena Pharmaceuticals, Inc. | 344 |
4 |
| Satiogen Pharmaceuticals, Inc. | 12 |
4 |
| Mesosil Inc. | 10 |
4 |
| The Regents of the University of California | 20815 |
3 |
| Commissariat à l'énergie atomique et aux energies alternatives | 11127 |
3 |
| Ajinomoto Co., Inc. | 2281 |
3 |
| Evologie, LLC | 10 |
3 |
| Farmington Pharma Development | 6 |
3 |
| Giuliani S.p.A. | 313 |
3 |
| Jiangsu Kanion Pharmaceutical Co., Ltd. | 92 |
3 |
| Newsouth Innovations Pty Limited | 623 |
3 |
| Sekisui Medical Co., Ltd. | 699 |
3 |
| Other owners | 179 |